AAMRI News
AAMRI News
-
Landmark $400 million anti-cancer drug royalty deal could be the first of many for Australia
28th July, 2017 · AAMRI News, Media Releases, News & EventsThe landmark $400 million deal made by the Walter and Eliza Hall Institute of Medical Research from the partial sale of royalty rights of the anti-cancer drug venetoclax shows the amazing... -
Submission to NHMRC consultation on a framework for assessment and funding of clinical trials and cohort studies
14th July, 2017 · AAMRI News, News & Events, Policy & Advocacy, SubmissionsWhile AAMRI’s submission supports many of the recommendations within the discussion paper, it offers a number of suggestions on improving processes relating to systematic reviews, assessment of...